BMS1P21: A Drug Target / Disease Biomarker (G100288974)

Target Name: BMS1P21

NCBI ID: G100288974

BMS1P21

Other Name(s): BMS1 pseudogene 21

BMS1P21: A Drug Target / Disease Biomarker

BMS1P21 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and kidneys. It is a member of the BMS1 family of proteins, which are known for their role in cell signaling and division. BMS1P21 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of BMS1P21 is its ability to interact with various signaling pathways. BMS1P21 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. It has been shown to interact with several different signaling pathways, including TGF-β, NF-kappa-B, and PI3K/AKT.

In addition to its role in cell signaling, BMS1P21 has also been shown to play a key role in the regulation of inflammation. BMS1P21 has been shown to interact with several different signaling pathways that are involved in inflammation, including NF-kappa-B, COX, and NF-伪尾.

These interactions between BMS1P21 and signaling pathways make it a promising target for drug development. By blocking the activity of BMS1P21, researchers hope to reduce the growth and spread of cancer cells, improve neurodegenerative disease symptoms, and alleviate symptoms of autoimmune disorders.

One of the challenges in studying BMS1P21 as a drug target is its complex structure. BMS1P21 is a large protein with multiple potential binding sites, and it is not clear how certain interactions between BMS1P21 and signaling pathways will translate into blocking the activity of BMS1P21 in a living organism.

Despite these challenges, researchers are actively working to understand the full potential of BMS1P21 as a drug target. By using various techniques, including live cell imaging, biochemical assays, and mass spectrometry, researchers are working to identify the specific interactions between BMS1P21 and signaling pathways that are responsible for its activity.

In addition to its potential as a drug target, BMS1P21 is also being studied as a biomarker for various diseases. Because BMS1P21 is expressed in a wide range of tissues and has been shown to play a role in several different signaling pathways, it is a promising marker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Researchers are currently working to develop methods for measuring the expression and activity of BMS1P21 in different tissues and to determine its potential as a biomarker for these diseases. By doing so, they hope to be able to use BMS1P21 as a diagnostic tool and as a target for drug development in a variety of diseases.

Overall, BMS1P21 is a protein that has the potential to be a drug target or biomarker for a wide range of diseases. As research continues to uncover the full implications of its interactions with signaling pathways, researchers are confident that BMS1P21 will prove to be a valuable tool for the study of these diseases and for the development of new treatments.

Protein Name: BMS1 Pseudogene 21

The "BMS1P21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BMS1P21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets